Cannabis-Related Securities Monthly Update | September 2023
With the hysteria over The announcement that the US Department of Health and Human Services recommended rescheduling cannabis to Schedule III from Schedule I no... Read more.
CRB Monitor Chart of the Month | September 2023
This month we take a closer look at the near-term health of the largest 20 pure play Tier 1 CRBs, as we consider what investors have to look forward to given th... Read more.